Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management

Like other sensory systems, olfactory function deteriorates with age. Epidemiological studies have revealed that the incidence of olfactory dysfunction increases at the age of 60 and older and males are more affected than females. Moreover, smoking, heavy alcohol use, sinonasal diseases, and Down’s...

Full description

Bibliographic Details
Main Authors: Kenji Kondo, Shu Kikuta, Rumi Ueha, Keigo Suzukawa, Tatsuya Yamasoba
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnagi.2020.00208/full
_version_ 1818417239736451072
author Kenji Kondo
Shu Kikuta
Rumi Ueha
Keigo Suzukawa
Tatsuya Yamasoba
author_facet Kenji Kondo
Shu Kikuta
Rumi Ueha
Keigo Suzukawa
Tatsuya Yamasoba
author_sort Kenji Kondo
collection DOAJ
description Like other sensory systems, olfactory function deteriorates with age. Epidemiological studies have revealed that the incidence of olfactory dysfunction increases at the age of 60 and older and males are more affected than females. Moreover, smoking, heavy alcohol use, sinonasal diseases, and Down’s syndrome are associated with an increased incidence of olfactory dysfunction. Although the pathophysiology of olfactory dysfunction in humans remains largely unknown, studies in laboratory animals have demonstrated that both the peripheral and central olfactory nervous systems are affected by aging. Aged olfactory neuroepithelium in the nasal cavity shows the loss of mature olfactory neurons, replacement of olfactory neuroepithelium by respiratory epithelium, and a decrease in basal cell proliferation both in the normal state and after injury. In the central olfactory pathway, a decrease in the turnover of interneurons in the olfactory bulb (OB) and reduced activity in the olfactory cortex under olfactory stimulation is observed. Recently, the association between olfactory impairment and neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), has gained attention. Evidence-based pharmacotherapy to suppress or improve age-related olfactory dysfunction has not yet been established, but preliminary results suggest that olfactory training using odorants may be useful to improve some aspects of age-related olfactory impairment.
first_indexed 2024-12-14T12:03:38Z
format Article
id doaj.art-ded2edf268b141f0a1cf4c28f1a73b9d
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-12-14T12:03:38Z
publishDate 2020-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-ded2edf268b141f0a1cf4c28f1a73b9d2022-12-21T23:01:55ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652020-07-011210.3389/fnagi.2020.00208557557Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical ManagementKenji KondoShu KikutaRumi UehaKeigo SuzukawaTatsuya YamasobaLike other sensory systems, olfactory function deteriorates with age. Epidemiological studies have revealed that the incidence of olfactory dysfunction increases at the age of 60 and older and males are more affected than females. Moreover, smoking, heavy alcohol use, sinonasal diseases, and Down’s syndrome are associated with an increased incidence of olfactory dysfunction. Although the pathophysiology of olfactory dysfunction in humans remains largely unknown, studies in laboratory animals have demonstrated that both the peripheral and central olfactory nervous systems are affected by aging. Aged olfactory neuroepithelium in the nasal cavity shows the loss of mature olfactory neurons, replacement of olfactory neuroepithelium by respiratory epithelium, and a decrease in basal cell proliferation both in the normal state and after injury. In the central olfactory pathway, a decrease in the turnover of interneurons in the olfactory bulb (OB) and reduced activity in the olfactory cortex under olfactory stimulation is observed. Recently, the association between olfactory impairment and neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), has gained attention. Evidence-based pharmacotherapy to suppress or improve age-related olfactory dysfunction has not yet been established, but preliminary results suggest that olfactory training using odorants may be useful to improve some aspects of age-related olfactory impairment.https://www.frontiersin.org/article/10.3389/fnagi.2020.00208/fullagingolfactory receptor neuronsbasal cellsregenerationolfactory bulbolfactory cortex
spellingShingle Kenji Kondo
Shu Kikuta
Rumi Ueha
Keigo Suzukawa
Tatsuya Yamasoba
Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management
Frontiers in Aging Neuroscience
aging
olfactory receptor neurons
basal cells
regeneration
olfactory bulb
olfactory cortex
title Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management
title_full Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management
title_fullStr Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management
title_full_unstemmed Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management
title_short Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management
title_sort age related olfactory dysfunction epidemiology pathophysiology and clinical management
topic aging
olfactory receptor neurons
basal cells
regeneration
olfactory bulb
olfactory cortex
url https://www.frontiersin.org/article/10.3389/fnagi.2020.00208/full
work_keys_str_mv AT kenjikondo agerelatedolfactorydysfunctionepidemiologypathophysiologyandclinicalmanagement
AT shukikuta agerelatedolfactorydysfunctionepidemiologypathophysiologyandclinicalmanagement
AT rumiueha agerelatedolfactorydysfunctionepidemiologypathophysiologyandclinicalmanagement
AT keigosuzukawa agerelatedolfactorydysfunctionepidemiologypathophysiologyandclinicalmanagement
AT tatsuyayamasoba agerelatedolfactorydysfunctionepidemiologypathophysiologyandclinicalmanagement